Consultant, Clinical Quality Assurance and Early Access Programs
Boost your chances before you apply.
ARAVAS INC
PA
Summary
The consultant will provide clinical quality assurance leadership and subject matter expertise for the Early Access Program. Responsibilities include vendor oversight, managing quality events, and ensuring compliance with GCP standards throughout the program lifecycle.
Job Description
Savara is seeking a Consultant of Clinical Quality Assurance and Early Access Programs to support the quality oversight and management of Good Clinical Practices (GCP) activities related to the Early Access Program (EAP), a program developed in order to provide investigational product to patients while the pivotal data from the IMPALA-2 Phase 3 clinical trial is under review by Health Authorities. This consultant will be responsible for vendor oversight, review of key project plan and dcouments, generation and management of associated quality events. This cnonsultant will identify risks, resolve issues, and escalate appropriately.
This contract is expected to be 120-170 hours per month for a duration of 12 months.
Working as a member of the Early Access Program (EAP) Team, drive strategy and execution of the following:
- Provide Clinical Quality Assurance (GCP) leadership and Subject Matter Expertise (SME) to the Early Access Program (EAP) Team
- Perform a gap assessment on vendors and identify a remediation plan as needed
- Assess the medical review process for proper documentation
- Provide strategy and execution in the anticipated transition of patients to commercial product (depending on Health Authority approval)
- Generate and coordinate appropriate and timely documentation of quality event management, including corrective action and preventive action (CAPA) plans, as necessary
- Author, revise and maintain QA Standard Operating Procedures (SOPs) as necessary
- Provide Clinical Quality Assurance SME to reviews of clinical protocols, amendments, informed consent forms, and other related documents, including associated regulatory submission documents
- Plan, conduct, and/or assist in internal and external service provider audits. Review audit reports, and any corresponding corrective and preventative actions for adequacy
- Previous experience providing GCP QA oversight to EAPs is strongly preferred.
- The consultant can be located anywhere within the U.S.
This is a consultant role.
#LI-Remote
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, MOLBREEVI*, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). MOLBREEVI is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of a large molecule. Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com.
Founded
2007
Company size
51-200 employees
Industry
Pharmaceutical Manufacturing
Org type
Public Company
Headquarters
United States
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, MOLBREEVI*, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). MOLBREEVI is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of a large molecule. Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com.
Founded
2007
Company size
51-200 employees
Industry
Pharmaceutical Manufacturing
Org type
Public Company
Headquarters
United States